Celera Genomics

45 West Gude Drive, Rockville, MD 20850 United States of America Tel: 240 453 3000 Fax: 240 453 4000

Celera is engaged principally in integrating advanced technologies to discover and develop new therapeutics. It intends to leverage its capabilities in proteomics, bioinformatics and genomics to identify and validate drug targets and to discover novel therapeutic candidates.

In November 2001, we acquired Axys Pharmaceuticals, a small molecule drug discovery and development company. As a result, we possess strong medicinal and structural chemistry and biology capabilities that should accelerate the development of our therapeutic discovery business.

The Celera Discovery System™ (CDS) online platform, marketed exclusively through the Knowledge Business of the Applied Biosystems Group, is an integrated source of information based on the human genome and other biological and medical sources

Further Information: http://www.celera.com